The Importance of Circulating and Disseminated Tumor Cells in Pancreatic Cancer

Abstract

Pancreatic Cancer is a lethal disease in a large part due to the systemic nature at the time of diagnosis. In those patients who undergo a potentially curative resection of pancreatic cancer the overwhelming majority will have systemic relapse. Circulating tumor cells (CTC) are an important mediator of the development of metastases. CTC have been identified in patients with clinically localized resectable pancreatic cancer and exist as several phenotypes. Mesenchymal and stem cell-like phenotypes of CTC predict early recurrence and worse survival. This review focuses on the current understanding of CTCs in pancreatic cancer and how this information can be used in developing more effective therapy in the future.